Antithymocyte immunoglobulin Other names: ATG Anti-thymocyte globulin

Therapeutic indications

Antithymocyte immunoglobulin is indicated for:

Prophylaxis of graft rejection

Population group: only adults (18 years old or older)

Preventive procedure and additionally Graft rejection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Steroid resistant graft rejection

Population group: only adults (18 years old or older)

Graft rejection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Antithymocyte immunoglobulin is contraindicated in the following cases:

Infections

Infectious disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: THYMOGLOBULINE Powder for solution for infusion
Structured Product Labeling (SPL/PLR) 2021: ATGAM Concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈